Merit Medical Systems (NASDAQ:MMSI) Announces Earnings Results, Beats Estimates By $0.08 EPS

Merit Medical Systems (NASDAQ:MMSI) released its earnings results on Tuesday. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.08, FiscalAI reports. Merit Medical Systems had a net margin of 8.02% and a return on equity of 14.27%. The business had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. Merit Medical Systems updated its FY 2026 guidance to 4.010-4.150 EPS.

Merit Medical Systems Stock Up 1.0%

Shares of Merit Medical Systems stock traded up $0.82 during trading hours on Tuesday, reaching $82.43. The company’s stock had a trading volume of 1,038,414 shares, compared to its average volume of 724,878. The company has a market capitalization of $4.89 billion, a P/E ratio of 42.27, a P/E/G ratio of 2.23 and a beta of 0.61. The stock’s fifty day simple moving average is $84.17 and its two-hundred day simple moving average is $85.01. Merit Medical Systems has a one year low of $77.62 and a one year high of $107.27. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.86 and a current ratio of 4.28.

Hedge Funds Weigh In On Merit Medical Systems

Several large investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP boosted its stake in Merit Medical Systems by 377.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after purchasing an additional 980,823 shares during the last quarter. Iron Triangle Partners LP bought a new position in shares of Merit Medical Systems in the fourth quarter valued at approximately $33,992,000. Champlain Investment Partners LLC purchased a new position in shares of Merit Medical Systems during the fourth quarter valued at approximately $32,359,000. Nomura Holdings Inc. grew its holdings in Merit Medical Systems by 195.1% during the third quarter. Nomura Holdings Inc. now owns 407,991 shares of the medical instruments supplier’s stock worth $33,957,000 after buying an additional 269,752 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in Merit Medical Systems by 12.7% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock worth $183,137,000 after buying an additional 234,682 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on MMSI shares. Canaccord Genuity Group upped their target price on Merit Medical Systems from $93.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, December 17th. Weiss Ratings restated a “hold (c)” rating on shares of Merit Medical Systems in a report on Monday, December 29th. Wells Fargo & Company reduced their price objective on shares of Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Robert W. Baird set a $108.00 target price on shares of Merit Medical Systems in a research report on Tuesday, December 16th. Finally, BTIG Research initiated coverage on shares of Merit Medical Systems in a report on Friday, February 6th. They issued a “buy” rating and a $107.00 price target for the company. Nine research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus price target of $105.67.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.